Mendelian
Mendelian is helping doctors diagnose rare genetic diseases faster.
Mendelian has raised €2.2M across 2 funding rounds from 2 investors, most recently a Grant round in Mar 2023. Based in London, UK; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.2M
€2,151,385
Funding rounds
2
Investors
2
distinct backers
Active since
2019-01
latest 2023-03
Funding by year
EUR raised per yearMendelian — funding by year — interactive chart.
Data table
| Mendelian — funding by year | |
|---|---|
| 2018 | €570k |
| 2023 | €1.6M |
Signals
High confidenceRaise-next likelihood9
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
- ▲ 11y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-03 | Grant | €1.6M | The Artificial Intelligence in Health and Care Awards | View deal → |
| 2019-01-01 | Other | €570k | Innovate UK | View deal → |